Search in:
Advanced Search

PREVIOUS ISSUE

Volume 46, Issue 1 2018, Pages 1-122
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 46, Issue 2 2018, Pages 123-226
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 46, Issue 3 2018, Pages 227-338
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 46, Issue 4 2018, Pages 339-484
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 47, Issue 1 2019, Pages 1-142
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 47, Issue 2 2019, Pages 143-238
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 47, Issue 3 2019, Pages 241-429
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 47, Issue 4 2019, Pages 433-558
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 48, Issue 1 2020, Pages 1-150
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 48, Issue 2 2020, Pages 151-254
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 48, Issue 3 2020, Pages 255-364
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 48, Issue 4 2020, Pages 365-460
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 49, Issue 1 2021, Pages 1-90
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 2, Issue 2 2022, Pages 91-176
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

PREVIOUS ISSUE

Volume 49, Issue 3 2022, Pages 177-256
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE

LATEST ISSUE

Volume 49, Issue 4 2022, Pages 257-342
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
OPEN ISSUE
< Back to issue

Review article

Vlatka Boričević Maršanić, Ljiljana Bolfan Karapetrić, Šime Mijić, Nina Dobrović
Pages: 279-308

Abstract

Psychotropic polypharmacy (PP) is defined as the practice of prescribing two or more medications for one or more diagnosed psychiatric disorders. Data on the rates of PP in pediatric population demonstrate that this practice is on the rise. The evidence base on the efficacy of psychotropic polypharmacy in pediatric psychiatric practice is limited. Due to the complexity of the etiology and severity of mental disorders in children, the use of PP is sometimes unavoidable. In such cases, each combination of drugs used must have its etiological and clinical justification because only then will PP be useful and justified, and not excessive and burdened with side effects. This review brings the main findings in this area with a clear conclusion that more high quality and longitudinal studies are needed to answer the questions of the effectiveness and safety of psychotropic polypharmacy in the treatment of mental disorders in children and adolescents. Until then, the attitude to combination pharmacotherapy should be conservative, and combining psychotropic medications should be closely monitored due to the specific concern of the risks of the increase of adverse events with polypharmacy.

RECENT ISSUES

All Issues >
Volume 49, Issue 4 2022, Pages 257-342
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
Volume 49, Issue 3 2022, Pages 177-256
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY
Volume 2, Issue 2 2022, Pages 91-176
UDK 615.89
ISSN 0303-7908
CODEN: SOCPSY

Social Psychiatry

Log in to Social Psychiatry Online Journal



Forgot password?

NEW USER >